Biora Therapeutics Inc (NAS:BIOR)
$ 0.678 0.02 (3.04%) Market Cap: 24.73 Mil Enterprise Value: 66.36 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 33/100

Q4 2022 Biora Therapeutics Inc Earnings Call Transcript

Mar 30, 2023 / 08:30PM GMT
Release Date Price: $2.67 (+0.75%)
Operator

Thank you for standing by. This is the conference operator. Welcome to the Biora Therapeutics Fourth Quarter 2022 Financial Results Conference Call. (Operator Instructions) The conference is being recorded. (Operator Instructions) I would now like to turn the conference over to Chuck Padala, Managing Director with LifeSci Advisors, Biora's Investor Relations firm. Please, Chuck, go ahead.

Charles Padala

Thank you, operator. Good afternoon, and welcome to the Biora Therapeutics Fourth Quarter 2022 Corporate Update and Financial Results Conference Call. Joining me on the call are Adi Mohanty, Chief Executive Officer; and Eric d'Esparbes, Chief Financial Officer.

Before I turn the call over to Mr. Mohanty, I would like to remind you that today's call will include forward-looking statements within the meaning of the federal securities laws, including, but not limited to, the types of statements identified as forward-looking in our annual report on Form 10-K that we will file later today and our subsequent reports filed with the SEC, which are all available on our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot